Timing of Postmenopausal Hormone Therapy a Critical Factor in Heart Disease Risk Says Study in Journal of Women's Health
Posted Oct 01 2008 8:20pm
The timing of estrogen replacement therapy in relation to a woman's age and time since onset of menopause may be a critical factor in whether hormone therapy protects against coronary heart disease, according to a report in the January/February 2006 issue (Vol. 15, No. 1) of Journal of Women's Health, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The paper is available free online at www.liebertpub.com/jwh.